ClinicalTrials.gov
ClinicalTrials.gov Menu

Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00586651
Recruitment Status : Completed
First Posted : January 4, 2008
Last Update Posted : October 8, 2015
Sponsor:
Information provided by (Responsible Party):
Teva Pharmaceutical Industries ( Cephalon )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2009
  Actual Study Completion Date : September 2010
  Certification/Extension First Submitted : August 22, 2013